Subgroups (mmol/L) | Endpoint | Treatment | Death, n (%) | p | OR (95% CI) | |
---|---|---|---|---|---|---|
No | Yes | |||||
Cl− < 107 | Death in hospital | With SB | 191 (71.54) | 76 (28.46) | 0.011 | 1.685 (1.124, 2.526) |
Without SB | 216 (80.90) | 51 (19.10) | 1 | |||
28-day death | With SB | 198 (74.16) | 69 (25.84) | 0.015 | 1.674 (1.101, 2.547) | |
Without SB | 221 (82.77) | 46 (17.23) | 1 | |||
107 ≤ Cl− < 113 | Death in hospital | With SB | 414 (92.62) | 33 (7.38) | 1.000 | 1.000 (0.606, 1.651) |
Without SB | 414 (92.62) | 33 (7.38) | 1 | |||
28-day death | With SB | 419 (93.74) | 28 (6.26) | 0.779 | 1.082 (0.624, 1.877) | |
Without SB | 421 (94.18) | 26 (5.82) | 1 | |||
Cl− ≥ 113 | Death in hospital | With SB | 422 (96.35) | 16 ( 3.65) | 0.001 | 0.367(0.203, 0.665) |
Without SB | 397 (90.64) | 41 ( 9.36) | 1 | |||
28-day death | With SB | 422 (96.35) | 16 ( 3.65) | 0.012 | 0.465 (0.252, 0.858) | |
Without SB | 405 (92.47) | 33 ( 7.53) | 1 |